Maxine Gowen insider trades
Open-market stock purchases and sales by Maxine Gowen, Unknown at Aclaris Therapeutics, Inc, from SEC Form 4 filings since Jan 11, 2010.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -92%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 5, 2026 | ACRS Aclaris Therapeutics, Inc | Bought (not open market) | — |
| Jun 4, 2026 | ACRS Aclaris Therapeutics, Inc | Bought (not open market) | — |
| Jun 4, 2026 | ACRS Aclaris Therapeutics, Inc | Bought (not open market) | — |
| May 19, 2026 | PASG Passage BIO, Inc | Bought (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
Companies traded
- ACRS Aclaris Therapeutics, Inc: other filings, last Jun 5, 2026
- PASG Passage BIO, Inc: other filings, last May 19, 2026
- MRUS Merus NV: other filings, last Dec 12, 2025
- ACGN Aceragen, Inc: 1 sale, last Aug 10, 2023
- IDRA Idera Pharmaceuticals, Inc: 1 buy, last Jun 23, 2022
- AKBA Akebia Therapeutics, Inc: 1 buy, 1 sale, last Jun 8, 2020
- TRVN Trevena Inc: 4 buys, last May 13, 2020
- HGSI Human Genome Sciences Inc: 1 sale, last Jul 30, 2012